Turnstone Biologics Corp. Lease, Cost
Turnstone Biologics Corp. reported Lease, Cost of $97.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2025-08-08
- Turnstone Biologics Corp. lease, cost for the quarter ending 2025-06-30 was $97.00K, a 75.63% decline year-over-year.
- Turnstone Biologics Corp. lease, cost for the quarter ending 2025-03-31 was $366.00K, a 8.04% decline year-over-year.
- Turnstone Biologics Corp. lease, cost for the quarter ending 2024-12-31 was $370.00K, a 0.00% change year-over-year.
- Turnstone Biologics Corp. lease, cost for the quarter ending 2024-09-30 was $392.00K, a 18.79% increase year-over-year.
- Turnstone Biologics Corp. lease, cost for fiscal 2024 was $1.56M, a 2.99% decline from fiscal 2023.
- Turnstone Biologics Corp. lease, cost for fiscal 2023 was $1.61M, a 28.62% decline from fiscal 2022.
- Turnstone Biologics Corp. lease, cost for fiscal 2022 was $2.25M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-06-30 | $97.00K 10-Q · filed 2025-08-08 | $463.00K 10-Q · filed 2025-08-08 | $833.00K derived: sum of 3 quarters · filed 2025-08-08 | $1.23M derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | $366.00K 10-Q · filed 2025-05-09 | $736.00K derived: sum of 2 quarters · filed 2025-05-09 | $1.13M derived: sum of 3 quarters · filed 2025-05-09 | $1.53M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | $370.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $762.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.16M derived: sum of 3 quarters · filed 2025-08-08 | $1.56M 10-K · filed 2025-03-31 |
| 2024-09-30 | $392.00K 10-Q · filed 2024-11-12 | $790.00K derived: sum of 2 quarters · filed 2025-08-08 | $1.19M 10-Q · filed 2024-11-12 | $1.56M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | $398.00K 10-Q · filed 2025-08-08 | $796.00K 10-Q · filed 2025-08-08 | $1.17M derived: sum of 3 quarters · filed 2025-08-08 | $1.50M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $398.00K 10-Q · filed 2025-05-09 | $768.00K derived: sum of 2 quarters · filed 2025-05-09 | $1.10M derived: sum of 3 quarters · filed 2025-05-09 | $1.53M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $370.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $700.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.13M derived: sum of 3 quarters · filed 2025-03-31 | $1.61M 10-K · filed 2025-03-31 |
| 2023-09-30 | $330.00K 10-Q · filed 2024-11-12 | $760.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.24M 10-Q · filed 2024-11-12 | $1.69M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $430.00K 10-Q · filed 2024-08-14 | $906.00K 10-Q · filed 2024-08-14 | $1.36M derived: sum of 3 quarters · filed 2024-08-14 | $2.02M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $476.00K 10-Q · filed 2024-05-13 | $931.00K derived: sum of 2 quarters · filed 2024-05-13 | $1.59M derived: sum of 3 quarters · filed 2024-05-13 | $2.14M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $455.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $1.12M derived: sum of 2 quarters · filed 2024-03-22 | $1.67M derived: sum of 3 quarters · filed 2024-03-22 | $2.25M 10-K · filed 2024-03-22 |
| 2022-09-30 | $661.00K 10-Q · filed 2023-11-13 | $1.21M derived: sum of 2 quarters · filed 2023-11-13 | $1.79M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $551.00K 10-Q · filed 2023-09-01 | $1.13M 10-Q · filed 2023-09-01 |